Zhu, G., Ren, D., Lei, X., Shi, R., Zhu, S., Zhou, N., . . . XU, S. (2021). Mutations associated with no durable clinical benefit to immune checkpoint blockade in Non-S-Cell lung cancer.
Chicago Style CitationZhu, Guangsheng, et al. Mutations Associated With No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer. 2021.
MLA CitationZhu, Guangsheng, et al. Mutations Associated With No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer. 2021.
Note: citation formatting may not correspond 100% to that defined by the respective standard, to manage citations it is recommended to use the software Zotero
, which allows the automatic upload of Oasisbr references.